COMP <GO>
RVTY vs JNJ // DIVIDEND YIELD & FCF PAYOUT SAFETY
Revvity Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: RVTY 2
— JNJ 13
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: RVTY
LAST: $157.00 (-5.30%) • MKT CAP: $18.50B
dividend-safety
0.18%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVTY VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVTY | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 25.50% | -22.40 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 48.2x | 18.5x | +29.70 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 2.75% | 2.97% | -0.22 | JNJ | /fcf-yield <GO> |
| Operating Margin | 12.50% | 34.70% | -22.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.40% | 28.50% | -20.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 6.00% | -2.30 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.18% | 0.00% | +0.18 | RVTY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.37 | 5.59 | -2.22 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 7.20% | -0.50 | RVTY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 60.4 | -5.25 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 1.08 | -0.13 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.3x | 23.0x | +48.30 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.50B | $662.49B | -$643.99B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVTY REV | JNJ REV | RVTY GROSS % | JNJ GROSS % | RVTY FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.86B | $94.19B | 44.0% | 67.9% | $509.4M | $19.70B |
| FY 2024 | $2.76B | $88.82B | 44.0% | 69.1% | $541.7M | $19.84B |
| FY 2023 | $2.75B | $85.16B | 44.0% | 44.0% | -$32.5M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVTY // BETA 0.95
JNJ // BETA 1.08